What leverage Cellyan HKPD HKPD Latest Quarter Earnings Cellyan logs zero revenue advances key drug pipeline progress OXSQ Oxford posts narrow Q4 2025 EPS miss shares dip 053 on mild negative investor sentiment EL Estee delivers modest Q1 2026 earnings beat shares rise nearly two percent on positive investor sentiment